Page 2 - Dr Reddy's Laboratories Limited

Covid: Dr Reddy's eyes Sputnik vaccine exports after domestic struggle

Now, Dr Reddy's is focusing on the single-dose Sputnik Light, as a booster shot or standalone, instead of the two-dose Sputnik V, a spokesperson said

BSE Healthcare index up 2%; Cipla, Alkem, Dr.Reddy's rally up to 8%

The pharma index had taken a breather over the past three months after displaying relative out-performance during CY20-21.

Without innovation Indian pharma cannot touch $130 bn by 2030: Industry

Sun Pharma says it eyes $1.5 bn from innovative products in 3-4 years

Fag-end buying in IT, banks lifts Sensex 831 pts at 60,138, Nifty at 17,930

The broader markets also logged strong gains, with the Midcap index up 1.8 per cent and the Smallcap index adding up 1.1 per cent

Dr Reddy's Laboratories working on enhancing Covid-19 portfolio

As for MSD's drug Molnupiravir, which is currently undergoing clinical trial in India, the company said it has already shared interim data with the drug regulator

Dr Reddys Labs gains 7% as profit grows 30% YoY in Q2, margins expand

Dr Reddy's global generic business grew 19 per cent YoY to Rs 4,743 crore driven by covid portfolio, new product launches and base business volume traction across key markets.

Dr Reddy's Lab receives USFDA approval to market Lenalidomide capsule

Dr Reddy's Laboratories on Tuesday said it has received approval from the US health regulator to market Lenalidomide capsules

Dr Reddy's Laboratories, Zydus Pharma recall products in US market

Dr Reddy's Laboratories, Inc, the US arm of Dr Reddy's Laboratories, is recalling 37,560 bottles of Tizanidine HCl tablets, USP 4 mg

India's worst-performing stock in July may rebound if history is any guide

Shares of pharma firm Dr Reddy's Labs have rallied about 15% after losing steam

DRDO to get 2% royalty from Dr Reddy's on sale of Covid drug 2-DG in India

The drug comes in powder form in sachet and is taken orally by dissolving it in water.

Nifty Pharma index slips 5%, records sharpest intra-day fall in 7 months

Alembic Pharma and Dr Reddy's Labs plunged 12% and 11%, respectively in intra-day trade post their June quarter results

Sputnik V soft launched in over 50 cities in India: Dr Reddy's Laboratories

Dr Reddys Laboratories Ltd, which soft-launched Russia's Covid-19 vaccine, Sputnik V here on May 14 has expanded the pilot project to over 50 other cities and towns in the country

Sputnik V second dose shortage to delay India's full rollout: Dr Reddy's

Dr. Reddy's had received about 3 million first doses by June 1 and about 360,000 doses of the second by early this month, the company and the Indian government have said

Nifty outlook & trading ideas by HDFC Sec: Buy Bajaj Finance, Dr Reddy's

Bajaj Finance's stock price has broken out from symmetrical triangle on the daily charts, and rising volumes have confirmed the breakout

Dr Reddy's bullish on OTC products sale through Amazon, others in US

Dr Reddy's first began selling its OTC Habitrol brand nicotine patches on Amazon in 2016, as an experiment.

Sensex, Nifty post fourth straight weekly rise; Dr Reddy's rises over 3%

After rising 341 points, the Sensex settled 174 points, or 0.33 per cent, higher at 52,475

Hyderabad's Rockwell collaborates with Dr Reddy's Lab for Sputnik V rollout

Rockwell Industries has got orders for 750 Covid19 vaccine freezers from hospitals and institutions.

Dr Reddy's lines up Rs 1,000 cr capex for current fiscal on growth outlook

Dr Reddy's Laboratories has earmarked a Capex of around Rs 1,000 crore for the current fiscal as it remains positive about sustaining its growth trends in the current fiscal, top company official said

Shilpa Medicare jumps 26% in 2 days on tie-up with DRL for Covid vaccine

The company has entered into a three-year Definitive Agreement with Dr. Reddy's for production-supply of the Sputnik V vaccine

Russia's Sputnik V vaccine for Covid priced at Rs 948 plus 5% GST in India

Inoculation could be cheaper when it is manufactured domestically, says Hyderabad company.